Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Winkler, JK; Sies, K; Fink, C; Toberer, F; Enk, A; Deinlein, T; Hofmann-Wellenhof, R; Thomas, L; Lallas, A; Blum, A; Stolz, W; Abassi, MS; Fuchs, T; Rosenberger, A; Haenssle, HA.
Melanoma recognition by a deep learning convolutional neural network-Performance in different melanoma subtypes and localisations.
Eur J Cancer. 2020; 127:21-29 Doi: 10.1016/j.ejca.2019.11.020
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Hofmann-Wellenhof Rainer
Kränke Teresa Maria
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: Deep learning convolutional neural networks (CNNs) show great potential for melanoma diagnosis. Melanoma thickness at diagnosis among others depends on melanoma localisation and subtype (e.g. advanced thickness in acrolentiginous or nodular melanomas). The question whether CNN may counterbalance physicians' diagnostic difficulties in these melanomas has not been addressed. We aimed to investigate the diagnostic performance of a CNN with approval for the European market across different melanoma localisations and subtypes. METHODS: The current market version of a CNN (Moleanalyzer-Pro®, FotoFinder Systems GmbH, Bad Birnbach, Germany) was used for classifications (malignant/benign) in six dermoscopic image sets. Each set included 30 melanomas and 100 benign lesions of related localisations and morphology (set-SSM: superficial spreading melanomas and macular nevi; set-LMM: lentigo maligna melanomas and facial solar lentigines/seborrhoeic keratoses/nevi; set-NM: nodular melanomas and papillomatous/dermal/blue nevi; set-Mucosa: mucosal melanomas and mucosal melanoses/macules/nevi; set-AMskin: acrolentiginous melanomas and acral (congenital) nevi; set-AMnail: subungual melanomas and subungual (congenital) nevi/lentigines/ethnical type pigmentations). RESULTS: The CNN showed a high-level performance in set-SSM, set-NM and set-LMM (sensitivities >93.3%, specificities >65%, receiver operating characteristics-area under the curve [ROC-AUC] >0.926). In set-AMskin, the sensitivity was lower (83.3%) at a high specificity (91.0%) and ROC-AUC (0.928). A limited performance was found in set-mucosa (sensitivity 93.3%, specificity 38.0%, ROC-AUC 0.754) and set-AMnail (sensitivity 53.3%, specificity 68.0%, ROC-AUC 0.621). CONCLUSIONS: The CNN may help to partly counterbalance reduced human accuracies. However, physicians need to be aware of the CNN's limited diagnostic performance in mucosal and subungual lesions. Improvements may be expected from additional training images of mucosal and subungual sites.
Find related publications in this database (using NLM MeSH Indexing)
Aged - administration & dosage
Case-Control Studies - administration & dosage
Deep Learning - administration & dosage
Female - administration & dosage
Follow-Up Studies - administration & dosage
Humans - administration & dosage
Male - administration & dosage
Melanoma - classification, diagnosis
Middle Aged - administration & dosage
Neural Networks, Computer - administration & dosage
Prognosis - administration & dosage
ROC Curve - administration & dosage
Retrospective Studies - administration & dosage

Find related publications in this database (Keywords)
Melanoma
Nevi
Dermoscopy
Deep learning
Convolutional neural network
© Med Uni GrazImprint